Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.72 EUR
−43.21 M EUR
4.35 M EUR
15.52 M
About NYXOAH SA
Sector
Industry
CEO
Olivier Taelman
Website
Headquarters
Mont-Saint-Guibert
Founded
2009
ISIN
BE0974358906
FIGI
BBG00YM3BLL2
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 5YI is 9.42 EUR — it has decreased by −1.21% in the past 24 hours. Watch NYXOAH S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange NYXOAH S.A. stocks are traded under the ticker 5YI.
5YI stock has fallen by −2.20% compared to the previous week, the month change is a 4.04% rise, over the last year NYXOAH S.A. has showed a −33.19% decrease.
We've gathered analysts' opinions on NYXOAH S.A. future price: according to them, 5YI price has a max estimate of 17.80 EUR and a min estimate of 11.00 EUR. Watch 5YI chart and read a more detailed NYXOAH S.A. stock forecast: see what analysts think of NYXOAH S.A. and suggest that you do with its stocks.
5YI stock is 5.16% volatile and has beta coefficient of 1.26. Track NYXOAH S.A. stock price on the chart and check out the list of the most volatile stocks — is NYXOAH S.A. there?
Today NYXOAH S.A. has the market capitalization of 334.24 M, it has decreased by −1.90% over the last week.
Yes, you can track NYXOAH S.A. financials in yearly and quarterly reports right on TradingView.
NYXOAH S.A. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
5YI earnings for the last quarter are −0.50 EUR per share, whereas the estimation was −0.45 EUR resulting in a −9.17% surprise. The estimated earnings for the next quarter are −0.47 EUR per share. See more details about NYXOAH S.A. earnings.
NYXOAH S.A. revenue for the last quarter amounts to 1.27 M EUR, despite the estimated figure of 1.34 M EUR. In the next quarter, revenue is expected to reach 2.03 M EUR.
5YI net income for the last quarter is −17.06 M EUR, while the quarter before that showed −13.12 M EUR of net income which accounts for −29.98% change. Track more NYXOAH S.A. financial stats to get the full picture.
No, 5YI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 26, 2025, the company has 146.00 employees. See our rating of the largest employees — is NYXOAH S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NYXOAH S.A. EBITDA is −49.36 M EUR, and current EBITDA margin is −995.54%. See more stats in NYXOAH S.A. financial statements.
Like other stocks, 5YI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NYXOAH S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NYXOAH S.A. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NYXOAH S.A. stock shows the buy signal. See more of NYXOAH S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.